XML 25 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 30, 2015
Dec. 31, 2014
Dec. 25, 2013
Cash flows from operating activities:      
Net income $ 35,976 $ 32,725 $ 24,572
Adjustments to reconcile net income to cash flows provided by operating activities:      
Depreciation and amortization 21,472 21,218 21,501
Operating (gains), losses and other charges, net 2,366 1,270 7,071
Amortization of deferred financing costs 507 483 497
Loss (gain) on early extinguishments of debt 225 (33) 2,226
(Gain) loss on the change in fair value of interest rate caps 0 (11) 42
Deferred income tax expense 14,006 13,215 9,100
Reversal of tax valuation allowance (130) (270) (420)
Share-based compensation 6,635 5,846 4,852
Decrease (increase) in assets:      
Receivables 1,440 (1,119) 116
Inventories (166) (71) 9
Other current assets (6,466) (259) 984
Other assets (78) (2,118) (2,110)
Increase (decrease) in liabilities:      
Accounts payable 2,345 1,561 (5,520)
Accrued salaries and vacations 4,060 2,648 (2,545)
Accrued taxes 182 871 101
Other accrued liabilities 9,479 114 (746)
Other noncurrent liabilities and deferred credits (11,216) (1,159) (2,688)
Net cash flows provided by operating activities 80,637 74,911 57,042
Cash flows from investing activities:      
Capital expenditures (26,977) (22,076) (16,818)
Acquisition of restaurants and real estate (5,803) 0 (3,980)
Proceeds from disposition of property 95 64 1,582
Collections on notes receivable 1,740 2,289 4,779
Issuance of notes receivable (1,790) (1,566) (2,033)
Net cash flows used in investing activities (32,735) (21,289) (16,470)
Cash flows from financing activities:      
Revolver borrowings 231,000 32,200 124,200
Revolver payments (121,250) (42,200) (28,950)
Term loan borrowings 0 0 60,000
Long-term debt payments (58,344) (7,237) (176,729)
Debt transaction costs 0 0 (366)
Deferred financing costs (1,716) 0 (1,374)
Purchase of treasury stock (92,644) (36,058) (25,039)
Purchase of equity forward contract (13,111) 0 0
Proceeds from exercise of stock options 732 2,169 2,955
Tax withholding on share-based payments (982) (419) (796)
Tax benefit (expense) for share-based compensation 2,648 (337) (387)
Net bank overdrafts 4,362 (1,609) (4,708)
Net cash flows used in financing activities (49,305) (53,491) (51,194)
(Decrease) increase in cash and cash equivalents (1,403) 131 (10,622)
Cash and cash equivalents at beginning of period 3,074 2,943 13,565
Cash and cash equivalents at end of period $ 1,671 $ 3,074 $ 2,943